DocMorris is a leading company in the fields of online pharmacy, marketplace, and professional healthcare services. Founded in 1993 and headquartered in Switzerland, their purpose is to deliver effective and empathetic healthcare to everyone, anytime, anywhere in one click. With a strong presence and trusted brands across Europe, DocMorris operates Germany's largest online pharmacy and leads the marketplace for health and personal care products in Southern Europe. In 2023, about 1,900 employees in Germany, the Netherlands, Spain, France, and Switzerland generated an external revenue of CHF 1,038 million (excluding the Swiss business sold in 2023), serving over 9 million active customers.
The latest investment in DocMorris was a Fr.200.00M post-IPO debt investment on 18 April 2024. The investors involved in this funding round are not specified.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Debt | Fr.200.00M | - | 18 Apr 2024 | |
| Post-IPO Debt | Fr.95.00M | - | 01 Sep 2022 | |
| Post-IPO Equity | Fr.44.00M | - | 01 Sep 2022 |
No recent news or press coverage available for DocMorris.
We care about your data, and we'd love to use cookies make your experience better.
